As a result of, in accordance with previously announced information, the directed issue of 2,888,888,888 Class B shares resolved on 3 July 2026 as well as the directed issue of an additional number of 868,702,560 Class B shares resolved on 8 July 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed.
Through the above-mentioned changes, the total number of shares in Episurf as of 31 July 2026 amounts to 10,688,429,393, of which 473,357 are Class A shares and 10,687,956,036 are Class B shares, and the total number of votes in Episurf amounts to 10,689,376,107.
For further information, please contact:
Jens Andersson, CEO, Episurf Medical
Tel: +46 (0) 768 55 67 02
Email: jens.andersson@episurf.com
This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 09:45 CEST on 1 August 2026.
About Episurf
Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The Company’s objective is to create value growth through the acquisition and management of Nordic properties. The Company also has a medical technology operation based on the individualized implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. Episurf Medical’s head office is in Stockholm, Sweden.
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] =>
[HtmlContact:protected] =>
[HtmlTitle:protected] => <h1 style="line-height:120%"><span style="font-family:arial,helvetica,sans-serif"><strong>Change in number of shares and votes in Episurf Medical</strong></span></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => As a result of, in accordance with previously announced information, the directed issue of 2,888,888,888 Class B shares resolved on 3 July 2026 as well as the directed issue of an additional number of 868,702,560 Class B shares resolved on 8 July 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed.
Through the above-mentioned changes, the total number of shares in Episurf as of 31 July 2026 amounts to 10,688,429,393, of which 473,357 are Class A shares and 10,687,956,036 are Class B shares, and the total number of votes in Episurf amounts to 10,689,376,107.
For further information, please contact:
Jens Andersson, CEO, Episurf Medical
Tel: +46 (0) 768 55 67 02
Email: jens.andersson@episurf.com
This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 09:45 CEST on 1 August 2026.
About Episurf
Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The Company’s objective is to create value growth through the acquisition and management of Nordic properties. The Company also has a medical technology operation based on the individualized implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. Episurf Medical’s head office is in Stockholm, Sweden.
[HtmlBody:protected] => <p style="margin-bottom:11px;margin-top:12px; text-align:justify"><span><strong><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">As a result of, in accordance with previously announced information, the directed issue of 2,888,888,888 Class B shares resolved on 3 July 2026 as well as the directed issue of an additional number of 868,702,560 Class B shares resolved on 8 July 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed.</span></span></strong></span></p>
<p style="margin-bottom:16px; text-align:justify"><span><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">Through the above-mentioned changes, the total number of shares in Episurf as of 31 July 2026 amounts to 10,688,429,393, of which 473,357 are Class A shares and 10,687,956,036 are Class B shares, and the total number of votes in Episurf amounts to 10,689,376,107.</span></span></span></p>
<p style="margin-bottom:16px; text-align:justify"><span><strong><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">For further information, please contact:</span></span></strong></span></p>
<p style="text-align:justify"><span><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">Jens Andersson, CEO, Episurf Medical</span></span></span></p>
<p style="text-align:justify"><span><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">Tel: +46 (0) 768 55 67 02</span></span></span></p>
<p style="margin-bottom:16px; text-align:justify"><span><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">Email: jens.andersson@episurf.com</span></span></span></p>
<p style="margin-bottom:16px; text-align:justify"><span><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif"><em><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 09:45 CEST on 1 August 2026.</span></span></em></span></span></span></p>
<p style="margin-bottom:16px; text-align:justify"><span><strong><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">About Episurf</span></span></strong></span></p>
<p style="margin-bottom:16px; text-align:justify"><span><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif"><em><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">Episurf Medical is a property company with exposure to a diversified portfolio of property assets. The Company’s objective is to create value growth through the acquisition and management of Nordic properties. The Company also has a medical technology operation based on the individualized implant Episealer® and associated surgical instruments, which are used to treat cartilage injuries in joints. </span></span></em><em><span style="font-size:9pt"><span style="font-family:arial,helvetica,sans-serif">Episurf Medical’s head office is in Stockholm, Sweden.</span></span></em></span></span></span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => EU Transparency SE
[Name:protected] => SeFsaCategoryCode
[Value:protected] => S8
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => OMX Filing (OMX CNS)
[Name:protected] => OMX CategoryCode
[Value:protected] => 075
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] =>
[Contact:protected] =>
[Header:protected] =>
[Keywords:protected] => Array
(
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 5403807
[EncryptedId:protected] => 42A155A8EA54CC9B
[IsRegulatory:protected] => 1
[PublishDate:protected] => 2026-08-01T07:45:00Z
[LastChangeDate:protected] => 2026-08-01T07:45:19.347Z
[Title:protected] => Change in number of shares and votes in Episurf Medical
[Intro:protected] =>
[IptcCode:protected] => 04004003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/change-in-number-of-shares-and-votes-in-episurf-medical,c4379185
[LanguageVersions:protected] => Array
(
[0] => CisionBlockPro\Cision\LanguageVersion Object
(
[Code:protected] => sv
[ReleaseId:protected] => 5403806
)
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)